GLP-1 Agonists and Weight Loss Therapy - Efficacy and The Side Effects
Editors Note: Please see update of 1.9.26 for recent developments, including Retatrutide --------------------------- Weight loss therapies using GLP-1 agonists have been implicated in the news recently as having a tendency to cause gallstones, and in some cases more serious gall-bladder damage. A recent report confirmed that there has been a marked rise in gall-bladder removals in UK over the last few years, and MHRA have recently updated their guidance on weight loss jabs. Should we have expected this, and what might be the consequences ? The short answer to this question is …Yes - this particular side effect was predictable, particularly after longer-term exposure..... To explain this more fully, we first need a little background. GLP-1 agonists are one of the most successful weight-loss inducing agents produced by Big Pharma of recent times; they have already generated a level of demand in the otherwise healthy population which far outstrips the available supply. Origi...